Fig. 1From: Erythropoietin Therapy for Acute Stroke Is Both Safe and BeneficialPercentile distribution analysis of NIH stroke scale for placebo and rhEPO-treated patients (A) upon admission (baseline); (B) at day 30 after treatment. Note the remarkable dissociation of curves over time for moderately to severely affected patients.Back to article page